Supplementary Data 1. Summary of Pancreatic Ductal Adenocarcinoma Cases Analyzed																		Case ID	Alternate ID	Analysis Type	Tumor Nuclei Sorted Status	Age at Surgery	Histology	Gender	Differentiation	Tumor Size (cm)	Tumor Stage	Neoadjuvant	Adjuvant	Progression Free Survival (Months)	Progression Free Survival	Overall Survival (Months)	Overall Survival	"MLL, MLL2 or MLL3"	ARID1A	"MLL, MLL2, MLL3 or ARID1A"CGPA217	22210-0012	Whole Exome Sequencing	Sorted	54	Adenocarcinoma	Male	Moderate	5.4	IIA	No	Yes	41.9	0	41.9	0	Wild-Type	Wild-Type	Wild-TypeCGPA218	22210-0013	Whole Exome Sequencing	Not sorted	68	Adenocarcinoma	Male	Poor	1.4	IIB	No	Yes	45.8	0	45.8	0	Wild-Type	Wild-Type	Wild-TypeCGPA219	22210-0014	Whole Exome Sequencing	Not sorted	52	Adenocarcinoma	Male	Poor	4.5	IIB	No	Yes	2.5	1	5.2	1	Wild-Type	Wild-Type	Wild-TypeCGPA220	22210-0016	Whole Exome Sequencing	Sorted	47	Adenocarcinoma	Male	Poor	3	IIB	No	Yes	19.4	1	24.0	1	Wild-Type	Wild-Type	Wild-TypeCGPA221	22210-0021	Whole Exome Sequencing	Sorted	82	Adenocarcinoma	Female	Poor	2.2	IIA	No	No	7.4	1	10.3	1	Wild-Type	Wild-Type	Wild-TypeCGPA222	22210-0022	Whole Exome Sequencing	Not sorted	75	Adenocarcinoma	Male	Poor	3	IIB	No	Yes	3.3	1	8.6	1	Wild-Type	Wild-Type	Wild-TypeCGPA223	22210-0023	Whole Exome Sequencing	Not sorted	80	Adenocarcinoma	Male	Poor	3.6	IIB	No	Yes	39.6	0	39.6	0	MLL3	Wild-Type	MutantCGPA224	22210-0024	Whole Exome Sequencing	Not sorted	67	Adenocarcinoma	Female	Poor	3.7	IIB	No	Yes	2.6	1	10.2	1	Wild-Type	Wild-Type	Wild-TypeCGPA225	22210-0026	Whole Exome Sequencing	Not sorted	60	Adenocarcinoma	Female	Moderate	4	IIB	No	Yes	22.7	0	22.7	0	MLL	Wild-Type	MutantCGPA226	22210-0028	Whole Exome Sequencing	Sorted	70	Adenocarcinoma	Male	Poor	2.8	IIA	No	Yes	5.0	1	15.3	1	Wild-Type	Wild-Type	Wild-TypeCGPA227	22210-0029	Whole Exome Sequencing	Not sorted	47	Adenocarcinoma	Female	Poor	1.7	IIA	No	Yes	28.1	0	28.1	0	Wild-Type	Wild-Type	Wild-TypeCGPA228	22210-0034	Whole Exome Sequencing	Not sorted	76	Adenocarcinoma	Female	Moderate	4.5	IIB	No	Yes	24.9	1	36.6	0	MLL	Mutant	MutantCGPA229	22210-0035	Whole Exome Sequencing	Not sorted	72	Adenocarcinoma	Female	Poor	4.5	IIA	No	Yes	27.8	0	27.8	0	MLL2	Mutant	MutantCGPA230	22210-0039	Whole Exome Sequencing	Sorted	65	Adenocarcinoma	Male	Moderate	3.8	IIA	No	Yes	5.3	1	13.7	1	Wild-Type	Wild-Type	Wild-TypeCGPA231	22210-0040	Whole Exome Sequencing	Sorted	68	Adenocarcinoma	Male	Poor	4	IIB	No	Yes	20.4	1	35.5	0	MLL3	Wild-Type	MutantCGPA232	22210-0042	Whole Exome Sequencing	Sorted	58	Adenocarcinoma	Male	Moderate	3.1	IIB	No	Yes	5.9	1	9.4	1	Wild-Type	Wild-Type	Wild-TypeCGPA233	22210-0044	Whole Exome Sequencing	Not sorted	73	Adenocarcinoma	Male	Moderate	3	IIB	No	Yes	3.8	0	3.8	0	Wild-Type	Wild-Type	Wild-TypeCGPA234	22210-0053	Whole Exome Sequencing	Sorted	82	Adenocarcinoma	Male	Poor	4	IIA	No	Yes	10.5	1	14.7	1	Wild-Type	Wild-Type	Wild-TypeCGPA235	22210-0054	Whole Exome Sequencing	Sorted	85	Adenocarcinoma	Female	Moderate	4	IIB	No	No	20.1	1	28.5	0	Wild-Type	Wild-Type	Wild-TypeCGPA236	22210-0057	Whole Exome Sequencing	Sorted	58	Adenocarcinoma	Male	Poor	4	IIB	No	Yes	11.2	1	16.2	1	MLL2	Wild-Type	MutantCGPA237	22210-0061	Whole Exome Sequencing	Sorted	56	Adenocarcinoma	Female	Moderate	3.5	IIB	No	Yes	3.0	1	5.1	1	Wild-Type	Wild-Type	Wild-TypeCGPA238	22210-0062	Whole Exome Sequencing	Sorted	70	Adenocarcinoma	Male	Moderate	3	IIB	No	Yes	19.9	1	28.6	0	Wild-Type	Wild-Type	Wild-TypeCGPA239	22210-0064	Whole Exome Sequencing	Sorted	66	Adenocarcinoma	Female	Moderate	5.3	IIB	No	Yes	14.9	1	20.4	1	Wild-Type	Wild-Type	Wild-TypeCGPA240	22210-0065	Whole Exome Sequencing	Sorted	81	Adenocarcinoma	Male	Moderate	3	IIA	No	Yes	16.6	1	20.4	1	MLL3	Wild-Type	MutantCGPA241	22210-066	Targeted Analysis	Not sorted	78	Adenocarcinoma	Female	Poor	3	IIB	No	No	6.1	1	22.4	1	Wild-Type	Wild-Type	Wild-TypeCGPA242	22210-072	Targeted Analysis	Not sorted	65	Adenocarcinoma	Male	Moderate	3.5	IIB	No	Yes	16.5	1	21.3	1	Wild-Type	Wild-Type	Wild-TypeCGPA243	22210-074	Targeted Analysis	Not sorted	42	Adenocarcinoma	Male	Poor	8	IIB	No	Yes	2.2	1	9.0	1	Wild-Type	Wild-Type	Wild-TypeCGPA244	22210-077	Targeted Analysis	Not sorted	63	Adenocarcinoma	Female	Moderate	2.7	IIA	No	Yes	22.2	0	22.2	0	Wild-Type	Wild-Type	Wild-TypeCGPA245	22210-078	Targeted Analysis	Not sorted	62	Adenocarcinoma	Male	Moderate	4	IIB	No	Yes	10.6	1	18.5	1	Wild-Type	Wild-Type	Wild-TypeCGPA246	-	Targeted Analysis	Not sorted	76	Adenocarcinoma	Female 	Well	2.4	IIB	No	No	Not Available	Not Available	14.0	1	Wild-Type	Wild-Type	Wild-TypeCGPA247	-	Targeted Analysis	Not sorted	77	Adenocarcinoma	Male 	Poor	3.5	IIB	No	No	Not Available	Not Available	6.1	1	Wild-Type	Wild-Type	Wild-TypeCGPA248	-	Targeted Analysis	Not sorted	77	Adenocarcinoma	Male 	Poor	4.5	IIA	No	Yes	Not Available	Not Available	12.7	0	Wild-Type	Mutant	MutantCGPA249	-	Targeted Analysis	Not sorted	58	Adenocarcinoma	Male	Poor	5.9	IIB	Yes 	Yes	Not Available	Not Available	3.9	0	Wild-Type	Wild-Type	Wild-TypeCGPA250	-	Targeted Analysis	Not sorted	71	Adenocarcinoma	Male	Poor	4.3	IIB	No	Yes	Not Available	Not Available	9.0	1	Wild-Type	Wild-Type	Wild-TypeCGPA251	-	Targeted Analysis	Not sorted	75	Adenocarcinoma	Male	Poor	4	IIB	No	No	Not Available	Not Available	8.6	1	Wild-Type	Wild-Type	Wild-TypeCGPA252	-	Targeted Analysis	Not sorted	54	Adenocarcinoma	Female	Moderate	2	IIB	No	Yes	Not Available	Not Available	11.4	0	Wild-Type	Wild-Type	Wild-TypeCGPA253	-	Targeted Analysis	Not sorted	78	Adenocarcinoma	Male	Poor	2	IIA	No	Not Available	Not Available	Not Available	5.7	0	Wild-Type	Wild-Type	Wild-TypeCGPA254	-	Targeted Analysis	Not sorted	57	Adenocarcinoma	Male	Poor	2.5	IIB	No	Yes	Not Available	Not Available	11.9	0	Wild-Type	Wild-Type	Wild-TypeCGPA255	-	Targeted Analysis	Not sorted	90	Adenocarcinoma	Female	Poor	3.9	IIB	No	No	Not Available	Not Available	5.5	0	MLL3	Mutant	MutantCGPA256	-	Targeted Analysis	Not sorted	71	Adenocarcinoma	Female	Moderate	2.2	IIA	No	Yes	Not Available	Not Available	11.7	0	Wild-Type	Mutant	MutantCGPA257	-	Targeted Analysis	Not sorted	69	Adenocarcinoma	Male	Moderate	1.1	IIA	No	Yes	Not Available	Not Available	7.9	0	Wild-Type	Wild-Type	Wild-TypeCGPA258	-	Targeted Analysis	Not sorted	72	Adenocarcinoma	Male	Poor	3.4	IIB	No	Yes	Not Available	Not Available	10.3	0	Wild-Type	Wild-Type	Wild-TypeCGPA259	-	Targeted Analysis	Not sorted	72	Adenocarcinoma	Male	Poor	4	IIB	No	No	Not Available	Not Available	4.4	1	Wild-Type	Wild-Type	Wild-TypeCGPA260	-	Targeted Analysis	Not sorted	83	Adenocarcinoma	Male	Poor	3.5	IIA	Yes	No	Not Available	Not Available	1.1	0	Wild-Type	Wild-Type	Wild-TypeCGPA261	-	Targeted Analysis	Not sorted	55	Adenocarcinoma	Male	Poor	3.5	IIB	No	Yes	Not Available	Not Available	6.0	0	Wild-Type	Wild-Type	Wild-TypeCGPA262	-	Targeted Analysis	Not sorted	70	Adenocarcinoma	Female	Moderate	3.8	IIB	No	Yes	Not Available	Not Available	2.0	0	Wild-Type	Wild-Type	Wild-TypeCGPA263	-	Targeted Analysis	Not sorted	52	Adenocarcinoma	Male	Moderate	4.4	IIB	No	Yes	Not Available	Not Available	4.7	0	Wild-Type	Wild-Type	Wild-TypeCGPA264	-	Targeted Analysis	Not sorted	76	Adenocarcinoma	Male	Moderate	1.7	IIB	No	Not Available	Not Available	Not Available	2.1	0	Wild-Type	Wild-Type	Wild-TypeCGPLPA14	-	Targeted Analysis / dPCR	Not sorted	68	Adenocarcinoma	Male	Poor	3.5	IIa	No	Yes	6.7	1	13.1	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA15	-	Targeted Analysis / dPCR	Not sorted	70	Adenocarcinoma	Female	Well	3.5	IIb	No	Yes	6.9	1	12.1	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA16	-	Targeted Analysis / dPCR	Not sorted	56	Adenocarcinoma	Female	Moderate	3.2	IIb	No	Yes	5.7	1	18.5	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA17	-	Targeted Analysis / dPCR	Not sorted	65	Adenocarcinoma	Male	Well	2.5	IIb	No	Yes	10.2	1	11.4	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA19	-	Targeted Analysis / dPCR	Not sorted	73	Adenocarcinoma	Male	Poor	4.0	IIa	No	No	6.9	1	6.9	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA20	-	Targeted Analysis / dPCR	Not sorted	58	Adenocarcinoma	Female	Poor	1.5	IIb	No	Yes	10.1	1	41.8	0	MLL3	Wild-Type	MutantCGPLPA22	-	Targeted Analysis	Not sorted	68	Adenocarcinoma	Male	Moderate	0.8	IIb	No	Yes	1.3	1	9.2	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA23	-	Targeted Analysis / dPCR	Not sorted	58	Adenocarcinoma	Female	Moderate	3.4	IIb	No	Yes	4.2	1	5.6	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA24	-	Targeted Analysis / dPCR	Not sorted	59	Adenocarcinoma	Male	Moderate	Not Available	IIb	No	Yes	12.0	1	13.5	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA25	-	Targeted Analysis / dPCR	Not sorted	69	Adenocarcinoma	Female	Poor	1.0	IIb	No	Yes	4.5	1	5.0	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA26	-	Targeted Analysis / dPCR	Not sorted	64	Adenocarcinoma	Male	Well	4.0	IIb	No	Yes	1.8	1	5.5	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA27	-	Targeted Analysis / dPCR	Not sorted	59	Adenocarcinoma	Male	Moderate	2.0	IIb	No	Yes	2.5	1	2.5	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA28	-	Targeted Analysis / dPCR	Not sorted	79	Adenocarcinoma	Female	Well	3.0	IIb	No	Yes	15.5	1	34.6	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA31	-	Targeted Analysis / dPCR	Not sorted	37	Adenocarcinoma	Male	Moderate	4.0	IIb	No	Yes	18.4	1	37.1	0	Wild-Type	Wild-Type	Wild-TypeCGPLPA33	-	Targeted Analysis / dPCR	Not sorted	67	Adenocarcinoma	Female	Well	4.0	IIb	No	Yes	5.2	1	5.9	1	MLL2	Wild-Type	MutantCGPLPA34	-	Targeted Analysis / dPCR	Not sorted	73	Adenocarcinoma	Male	Well	8.0	IIb	No	Yes	5.3	1	11.6	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA35	-	Targeted Analysis / dPCR	Not sorted	77	Adenocarcinoma	Female	Moderate	3.0	IIb	No	Yes	8.1	1	9.8	1	Wild-Type	Mutant	MutantCGPLPA36	-	Targeted Analysis / dPCR	Not sorted	65	Adenocarcinoma	Male	Poor	3.0	IIb	No	Yes	35.2	0	35.2	0	Wild-Type	Wild-Type	Wild-TypeCGPLPA37	-	Targeted Analysis / dPCR	Not sorted	67	Adenocarcinoma	Female	Not Available	3.5	IIb	No	Yes	4.3	1	16.7	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA38	-	Targeted Analysis	Not sorted	65	Adenocarcinoma	Male	Moderate	1.0	IIa	No	Yes	24.1	1	34.2	0	Wild-Type	Wild-Type	Wild-TypeCGPLPA39	-	Targeted Analysis / dPCR	Not sorted	67	Adenocarcinoma	Female	Well	3.5	IIb	No	Yes	33.6	0	33.6	0	MLL2	Wild-Type	MutantCGPLPA40	-	Targeted Analysis / dPCR	Not sorted	64	Adenocarcinoma	Male	Well	2.5	IIb	No	Yes	14.1	1	15.0	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA41	-	Targeted Analysis / dPCR	Not sorted	69	Adenocarcinoma	Male	Well	4.5	IIb	No	Yes	7.4	1	15.0	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA42	-	Targeted Analysis / dPCR	Not sorted	73	Adenocarcinoma	Male	Moderate	4.5	IIb	No	Yes	10.7	1	20.9	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA43	-	Targeted Analysis / dPCR	Not sorted	69	Adenocarcinoma	Male	Well	2.0	IIa	No	No	26.8	1	32.2	0	MLL3	Wild-Type	MutantCGPLPA45	-	Targeted Analysis / dPCR	Not sorted	61	Adenocarcinoma	Female	Well	2.5	IIb	No	Yes	27.2	0	27.2	0	Wild-Type	Wild-Type	Wild-TypeCGPLPA46	-	Targeted Analysis	Not sorted	59	Adenocarcinoma	Female	Poor	2.0	IIb	No	Yes	5.3	1	9.5	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA50	-	Targeted Analysis / dPCR	Not sorted	77	Adenocarcinoma	Female	Well	2.2	IIb	No	Yes	10.3	1	17.5	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA51	-	Targeted Analysis / dPCR	Not sorted	49	Adenocarcinoma	Female	Not Available	3.0	IIb	No	Yes	29.2	0	29.2	0	Wild-Type	Wild-Type	Wild-TypeCGPLPA55	-	Targeted Analysis / dPCR	Not sorted	67	Adenocarcinoma	Male	Poor	3.0	IIb	No	Yes	7.8	1	9.7	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA56	-	Targeted Analysis / dPCR	Not sorted	62	Adenocarcinoma	Male	Well	2.0	IIb	No	Yes	15.2	1	25.2	0	Wild-Type	Wild-Type	Wild-TypeCGPLPA57	-	Targeted Analysis / dPCR	Not sorted	73	Adenocarcinoma	Male	Well	3.0	IIb	No	Yes	25.2	0	25.2	0	Wild-Type	Wild-Type	Wild-TypeCGPLPA60	-	Targeted Analysis / dPCR	Not sorted	53	Adenocarcinoma	Male	Moderate	3.0	IIb	No	Yes	11.2	1	24.3	0	Wild-Type	Wild-Type	Wild-TypeCGPLPA63	-	Targeted Analysis / dPCR	Not sorted	59	Adenocarcinoma	Male	Moderate	3.5	IIb	No	Yes	13.3	1	23.7	0	MLL2	Wild-Type	MutantCGPLPA65	-	Targeted Analysis / dPCR	Not sorted	66	Adenocarcinoma	Female	Moderate	12.5	IIb	No	Yes	8.1	1	23.3	0	Wild-Type	Wild-Type	Wild-TypeCGPLPA68	-	Targeted Analysis	Not sorted	59	Adenocarcinoma	Male	Poor	3.0	IIb	No	Yes	5.4	1	9.9	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA71	-	Targeted Analysis	Not sorted	64	Adenocarcinoma	Male	Well	1.0	IIb	No	Yes	16.1	1	22.6	0	Wild-Type	Wild-Type	Wild-TypeCGPLPA73	-	Targeted Analysis / dPCR	Not sorted	66	Adenocarcinoma	Male	Poor	4.0	IIb	No	Yes	5.3	1	6.7	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA74	-	Targeted Analysis	Not sorted	71	Adenocarcinoma	Female	Moderate	Not Available	IIb	No	Yes	22.1	0	22.1	0	Wild-Type	Mutant	MutantCGPLPA75	-	Targeted Analysis / dPCR	Not sorted	75	Adenocarcinoma	Female	Poor	7.0	IIb	No	Yes	5.4	1	6.7	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA77	-	Targeted Analysis / dPCR	Not sorted	69	Adenocarcinoma	Male	Moderate	2.0	IIb	No	Yes	21.4	0	21.4	0	Wild-Type	Wild-Type	Wild-TypeCGPLPA78	-	Targeted Analysis / dPCR	Not sorted	70	Adenocarcinoma	Male	Not Available	1.5	IIb	No	Yes	20.8	0	20.8	0	MLL3	Wild-Type	MutantCGPLPA80	-	Targeted Analysis / dPCR	Not sorted	70	Adenocarcinoma	Male	Well	2.0	IIb	No	Yes	20.6	0	20.6	0	Wild-Type	Wild-Type	Wild-TypeCGPLPA81	-	Targeted Analysis / dPCR	Not sorted	62	Adenocarcinoma	Male	Moderate	5.0	IIb	No	Yes	8.2	1	8.5	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA82	-	Targeted Analysis / dPCR	Not sorted	63	Adenocarcinoma	Male	Poor	2.7	IIb	No	Yes	4.0	1	4.1	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA83	-	Targeted Analysis / dPCR	Not sorted	72	Adenocarcinoma	Male	Poor	2.0	IIb	No	Yes	6.3	1	6.8	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA84	-	Targeted Analysis / dPCR	Not sorted	68	Adenocarcinoma	Female	Well	3.5	IIb	No	Yes	5.6	1	7.7	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA85	-	Targeted Analysis	Not sorted	77	Adenocarcinoma	Female 	Poor	2.3	IIb	No	No	17.8	0	17.8	0	Wild-Type	Mutant	MutantCGPLPA88	-	Targeted Analysis / dPCR	Not sorted	69	Adenocarcinoma	Female	Well	3.0	IIa	No	Yes	16.2	0	16.2	0	Wild-Type	Mutant	MutantCGPLPA89	-	Targeted Analysis / dPCR	Not sorted	62	Adenocarcinoma	Female	Moderate	2.7	IIb	No	Yes	15.6	0	15.6	0	Wild-Type	Wild-Type	Wild-TypeCGPLPA90	-	Targeted Analysis / dPCR	Not sorted	68	Adenocarcinoma	Male	Moderate	2.4	IIb	No	Yes	15.2	0	15.2	0	Wild-Type	Wild-Type	Wild-TypeCGPLPA91	-	Targeted Analysis	Not sorted	70	Adenocarcinoma	Female	Poor	3.5	IIb	No	Yes	14.4	0	14.4	0	Wild-Type	Wild-Type	Wild-TypeCGPLPA54	-	Targeted Analysis	Not sorted	70	Adenocarcinoma	Male	Moderate	3.5	IIb	No	Yes	1.9	1	1.9	1	Wild-Type	Wild-Type	Wild-TypeCGPLPA13	-	dPCR	Not sorted	47	Adenocarcinoma	Male	Well	3.5	III	No	Yes	9.3	1	12.5	1	Not Evaluated	Not Evaluated	Not EvaluatedCGPLPA29	-	dPCR	Not sorted	68	Adenocarcinoma	Female	Not Available	2.3	Ib	No	Yes	37.3	0	37.3	0	Not Evaluated	Not Evaluated	Not EvaluatedCGPLPA30	-	dPCR	Not sorted	65	Adenocarcinoma	Male	Not Available	2	III	No	Yes	9.6	1	12.9	1	Not Evaluated	Not Evaluated	Not EvaluatedCGPLPA64	-	dPCR	Not sorted	74	Adenocarcinoma	Female	Moderate	4	III	No	Yes	23.5	0	23.5	0	Not Evaluated	Not Evaluated	Not EvaluatedCGPLPA66	-	dPCR	Not sorted	77	Adenocarcinoma	Female	Moderate	1.6	III	No	Yes	12.8	1	22.8	0	Not Evaluated	Not Evaluated	Not EvaluatedCGPLPA72	-	dPCR	Not sorted	72	Adenocarcinoma	Male	Not Available	3	IIb	No	Yes	22.3	0	22.3	0	Not Evaluated	Not Evaluated	Not EvaluatedCGPLPA87	-	dPCR	Not sorted	65	Adenocarcinoma	Male	Well	Not Available	Ia	No	Yes	16.6	0	16.6	0	Not Evaluated	Not Evaluated	Not Evaluated																																																																																																																																																																																																																												